XML 34 R24.htm IDEA: XBRL DOCUMENT v3.23.1
Note 17 - Segment Reporting
 3 Months Ended
Mar. 31, 2023
Notes to Financial Statements  
Segment Reporting Disclosure [Text Block]

NOTE 17. SEGMENT REPORTING

 

The Company’s chief operating decision maker (“CODM”), who is the Company’s Chief Executive Officer, allocates resources and assesses performance based on financial information of the Company. The CODM reviews financial information presented for each reportable segment for purposes of making operating decisions and assessing financial performance.

 

Prior to the DERMAdoctor Acquisition in November 2021, the Company was managed as a single segment focused on commercializing Avenova Spray in the United States. After the DERMAdoctor Acquisition, the Company began managing and aggregating its operational and financial information in accordance with two reportable segments: (1) Eyecare & Wound Care and (2) Skincare. The Eyecare & Wound Care segment consists of products historically sold by NovaBay prior to the DERMAdoctor Acquisition. The Skincare segment consists of products acquired in the DERMAdoctor Acquisition and skincare products subsequently sold under the DERMAdoctor brand.

 

Select financial information for each segment is as follows:

 

  

Three Months

      

Three Months

     
  

Ended

  

Percentage

  

Ended

  

Percentage

 
  

March 31,

  

of Total Sales,

  

March 31,

  

of Total Sales,

 
  

2023

  

Net

  

2022

  

Net

 

Eyecare & Wound Care

 $2,339   75

%

 $2,230   68

%

Skincare

  785   25

%

  1,043   32

%

Total sales, net

 $3,124   100

%

 $3,273   100

%

 

 

  

Three Months

      

Three Months

     
  

Ended

  

Percentage

  

Ended

  

Percentage

 
  

March 31,

  

of Total

  

March 31,

  

of Total

 
  

2023

  

Operating Loss

  

2022

  

Operating Loss

 

Eyecare & Wound Care

 $(1,335)  77

%

 $(2,039)  86

%

Skincare

  (399)  23

%

  (343)  14

%

Total operating loss

 $(1,734)  100

%

 $(2,382)  100

%